title: Shift in phenotypic susceptibility suggests a competition mechanism in a case of acquired resistance to maraviroc.
authors.forename: Pierre
authors.initials: P
authors.lastname: Delobel
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Raymond
authors.forename: Maud
authors.initials: M
authors.lastname: Mavigner
authors.forename: Michelle
authors.initials: M
authors.lastname: Cazabat
authors.forename: Muriel
authors.initials: M
authors.lastname: Alvarez
authors.forename: Bruno
authors.initials: B
authors.lastname: Marchou
authors.forename: Patrice
authors.initials: P
authors.lastname: Massip
authors.forename: Jacques
authors.initials: J
authors.lastname: Izopet
mesh_terms: D000328:Adult; D003510:Cyclohexanes / Q000627:therapeutic use*; D024882:Drug Resistance, Viral / Q000235:genetics*; D023581:HIV Fusion Inhibitors / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy* / Q000235:genetics; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D008297:Male; D000077592:Maraviroc; D010641:Phenotype; D014230:Triazoles / Q000627:therapeutic use*
chemical_list: D003510:Cyclohexanes; D023581:HIV Fusion Inhibitors; D014230:Triazoles; D000077592:Maraviroc